HYPONIDD TABLET

Indications

• Skin conditions
• Wound healing
• Inflammatory skin disorders
• Respiratory ailments
• Gastrointestinal disorders

Dosage

Children: Specific dosing guidelines for pediatric use of asphaltum are not established. It is recommended to consult a healthcare provider for appropriate guidance.

Adults: Specific dosing guidelines for asphaltum are not established. It is typically used topically as needed for the treatment of skin conditions or as directed by a healthcare provider.

Mechanism of action

The exact mechanism of action of asphaltum is not fully understood, but it is thought to exert its effects through its anti-inflammatory properties, which may involve the inhibition of pro-inflammatory cytokines and the promotion of wound healing. It may also have a role in forming a protective barrier over wounds and affected areas, reducing the risk of infection.

Pharmacodynamics

Asphaltum demonstrates various pharmacological effects, including anti-inflammatory and antimicrobial activities. Its application can lead to improved healing in skin conditions by providing a protective layer and reducing inflammation. The exact pharmacodynamic profile can vary based on the formulation and method of application.

Pharmacokinetics

The pharmacokinetics of asphaltum are not well-characterized due to its topical usage and variable formulations. When applied topically, absorption through the skin may occur, although systemic absorption is generally minimal. The clearance and metabolism of asphaltum when used in this manner are not well-documented.

Adverse effects

• Skin irritation
• Allergic reactions
• Gastrointestinal disturbances

Precautions

• Use with caution in individuals with skin sensitivities
• Avoid contact with eyes and mucous membranes
• Not recommended for use in open wounds or broken skin

Pregnancy

Safety during pregnancy has not been established, use with caution.

Breast-feeding

Safety during breastfeeding has not been established, use with caution.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Topical ointment
• Pastes
• Creams

Indications

• Topical treatment for burns
• Wound healing
• Management of skin irritations
• Anti-inflammatory applications

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The mechanism of action of Aloe auriculata is primarily attributed to its bioactive compounds, such as anthraquinones, glycoproteins, and polysaccharides. These compounds exhibit anti-inflammatory effects by inhibiting the synthesis of pro-inflammatory cytokines and promoting the healing of wounds through enhanced cell proliferation and migration. Additionally, its antimicrobial properties are thought to arise from the ability of anthraquinones to disrupt the membranes of bacteria and fungi.

Pharmacodynamics

The pharmacodynamics of Aloe auriculata involve its ability to modulate immune responses, reduce inflammation, and promote cellular repair processes. The presence of compounds like aloin and other flavonoids may contribute to its antioxidant properties, helping to neutralize free radicals and reduce oxidative stress in tissues. These effects are beneficial in managing skin conditions, promoting wound healing, and providing symptomatic relief in inflammatory disorders.

Pharmacokinetics

Pharmacokinetic data specific to Aloe auriculata is limited. However, it is generally understood that the absorption of its active compounds occurs through topical application where they can exert local effects on the skin. Systemic absorption may vary based on the formulation and method of administration. The elimination pathways of the constituents of Aloe auriculata are not well characterized, indicating a need for further research to establish detailed pharmacokinetic profiles.

Pregnancy

There is insufficient data on the safety of Auriculata in pregnancy. Caution is advised when prescribing.

Breast-feeding

Limited information is available regarding the excretion of Auriculata in breast milk. Use with caution while breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Acne
• Eczema
• Psoriasis
• Diabetes management
• Malaria
• Intestinal worms
• Fungal infections
• Dental health (gingivitis)
• Skin conditions (antiseptic)

Dosage

Children: Paediatric dosing should be determined based on the specific formulation and condition being treated

Adults: Dosing varies widely based on the form of Azadirachta (e.g., oil, extract, capsules) and the condition being treated. It is recommended to consult specific product guidelines or a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in Azadirachta, particularly azadirachtin, exert their effects through multiple pathways. Azadirachtin acts primarily as an insect growth regulator, interfering with the hormonal processes of insects and leading to their eventual death. Additionally, it exhibits anti-inflammatory properties by inhibiting the production of pro-inflammatory cytokines and modulating immune responses. The antimicrobial activity is believed to arise from the ability of neem extracts to disrupt microbial cell membranes and inhibit their growth.

Pharmacodynamics

Azadirachta displays a range of pharmacodynamic effects, including anti-inflammatory, antipyretic, analgesic, and antimicrobial activities. Its immunomodulatory effects can enhance the body's defense mechanisms against pathogens. The various phytochemicals in neem contribute to these effects, making it a versatile therapeutic agent in traditional medicine.

Pharmacokinetics

The pharmacokinetics of Azadirachta compounds can vary significantly depending on the route of administration and the specific extract used. Generally, bioactive compounds in neem are absorbed and distributed throughout the body, with some metabolites being excreted via urine and feces. The half-life and metabolism of these compounds are influenced by factors such as dosage, formulation, and individual patient characteristics. However, detailed pharmacokinetic studies are limited.

Pregnancy

There is insufficient data on the safety of Azadirachta indica (neem) during pregnancy. It is advisable to avoid its use unless under professional guidance.

Breast-feeding

Limited information is available on the safety of Azadirachta indica during breastfeeding. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Respiratory disorders
• Digestive issues
• Skin diseases
• Anemia
• General health and wellness

Dosage

Children: Paediatric dosing of bhasma is also variable and should be determined based on the child's age, weight, and specific health concerns. Consultation with a healthcare professional experienced in Ayurvedic medicine is advised.

Adults: Dosage for adults can vary widely based on the specific type of bhasma and the condition being treated. It is recommended to refer to traditional Ayurvedic guidelines or consult a qualified practitioner for specific dosing.

Mechanism of action

The exact mechanism of action of bhasma is not fully understood, but it is believed to involve the bioactive compounds released during the calcination process, which may exert antioxidant, anti-inflammatory, and immunomodulatory effects. These properties can enhance physiological functions and promote the healing processes in the body.

Pharmacodynamics

Bhasma exhibits various pharmacological effects, which may include modulation of immune responses, enhancement of metabolic functions, and promotion of detoxification processes. The bioavailability of minerals and metals in bhasma can lead to improved physiological activity, potentially affecting enzymatic activities and cellular signaling pathways.

Pharmacokinetics

Pharmacokinetic data specific to bhasma is limited due to its complex composition and traditional preparation methods. However, it is generally thought to be absorbed through the gastrointestinal tract when ingested, with its effects being dose-dependent. The elimination and metabolism of the components may vary based on individual physiology and the specific formulation of bhasma used.

Pregnancy

The safety of bhasma during pregnancy has not been well studied. It is advisable to consult a healthcare professional before use.

Breast-feeding

The excretion of bhasma in breast milk is not well documented. Caution is advised, and consultation with a healthcare professional is recommended.

Storage

Bhasma should be stored in a cool, dry place, away from direct sunlight and moisture, to maintain its potency and effectiveness.

Indications

• Type 2 diabetes management
• Digestive disorders
• Anti-inflammatory support
• Antioxidant activity
• Weight management
• Blood sugar regulation

Dosage

Children: Refer to established guidelines for specific dosing based on the formulation and intended use.

Adults: Refer to established guidelines for specific dosing based on the formulation and intended use.

Mechanism of action

The active compounds in cassia, particularly cinnamaldehyde and coumarin, may exert their effects by modulating various metabolic pathways. Cinnamaldehyde has been shown to enhance insulin sensitivity, thereby improving glucose uptake in cells. The antioxidant properties of cassia may help reduce oxidative stress, which is implicated in various chronic diseases. Coumarin has been associated with anti-inflammatory effects and may influence blood coagulation pathways.

Pharmacodynamics

Cassia exhibits a range of pharmacodynamic effects primarily due to its bioactive compounds. Its anti-inflammatory properties can contribute to reduced inflammation markers in the body. The ability of cassia to potentially lower blood glucose levels is of particular interest, especially in the management of type 2 diabetes. Additionally, its antioxidant effects help protect cells from damage caused by free radicals.

Pharmacokinetics

The pharmacokinetics of cassia components can vary based on the specific compounds and their formulations. Generally, compounds like cinnamaldehyde are absorbed in the gastrointestinal tract and metabolized in the liver. The half-life and excretion pathways can vary, but many of the bioactive constituents are rapidly metabolized and eliminated. The systemic bioavailability of these compounds can be influenced by factors such as the form of cassia consumed and the presence of other dietary components.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Abdominal cramps
• Electrolyte imbalance
• Dehydration

Interactions

• May enhance the effect of diuretics
• May interact with medications that affect electrolyte levels

Precautions

• Use with caution in individuals with gastrointestinal disorders
• Monitor electrolyte levels in prolonged use
• Not recommended for long-term use

Pregnancy

Cassia is generally not recommended during pregnancy due to a lack of safety data. Consult a healthcare provider for guidance.

Breast-feeding

Use with caution while breastfeeding. Consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Dried leaves
• Powdered form
• Tea preparations

Indications

• Type 2 diabetes mellitus
• Hyperglycemia
• Dyslipidemia
• Weight management

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

Bitter melon is thought to exert its effects primarily through the modulation of glucose metabolism. The active compounds may enhance insulin sensitivity and promote glucose uptake by cells. Additionally, it may stimulate insulin secretion from the pancreas and inhibit gluconeogenesis in the liver. Some studies suggest that bitter melon may also possess antioxidant properties.

Pharmacodynamics

The pharmacodynamics of charantia involves its ability to lower blood glucose levels, improve lipid profiles, and exert anti-inflammatory effects. Through its active constituents, bitter melon can also influence various metabolic pathways, including those related to carbohydrate and lipid metabolism, contributing to its potential role in managing conditions such as type 2 diabetes.

Pharmacokinetics

The pharmacokinetics of charantia, including its absorption, distribution, metabolism, and excretion, are not well characterized due to limited clinical studies. However, it is believed that the active compounds are absorbed in the gastrointestinal tract, with varying bioavailability. The metabolism may involve conjugation, and the excretion of metabolites likely occurs via renal pathways. Further research is necessary to elucidate these pharmacokinetic parameters.

Adverse effects

• Gastrointestinal discomfort
• Diarrhea
• Nausea
• Hypoglycemia
• Allergic reactions

Interactions

• May enhance the effects of antidiabetic medications
• Potential interaction with anticoagulants due to blood sugar-lowering effects

Precautions

• Use with caution in patients with diabetes, monitoring blood glucose levels closely
• May affect blood sugar levels, requiring adjustment of diabetic medications
• Caution in patients with hypersensitivity to plants in the Cucurbitaceae family

Pregnancy

Limited data available; use with caution and consult healthcare provider.

Breast-feeding

Limited information available; consult healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Dried fruit extract
• Powdered whole fruit
• Capsules
• Liquid extract
• Tea

Indications

• Digestive disorders
• Liver disorders
• Appetite stimulation
• Anti-inflammatory conditions
• Antidiabetic effects

Dosage

Children: Refer to established herbal guidelines, as specific dosing may vary based on preparation and intended use.

Adults: Refer to established herbal guidelines, as specific dosing may vary based on preparation and intended use.

Mechanism of action

Chirata exhibits its pharmacological effects through various mechanisms, including the modulation of glucose metabolism, enhancement of insulin sensitivity, and promotion of liver function. The active compound swertiamarin may act on multiple pathways, influencing cellular signaling related to glucose uptake and lipid metabolism, and exhibiting anti-inflammatory effects by inhibiting pro-inflammatory cytokines.

Pharmacodynamics

The pharmacodynamics of chirata involves its interaction with multiple biochemical pathways. The bitter compounds stimulate the secretion of digestive enzymes, enhancing gut health and improving appetite. Additionally, chirata's anti-inflammatory properties may help in reducing oxidative stress and protecting against cellular damage. It has been shown to possess hepatoprotective effects, which can aid in the detoxification processes of the liver.

Pharmacokinetics

Chirata is primarily administered orally, and its active compounds are absorbed in the gastrointestinal tract. The pharmacokinetics, including absorption, distribution, metabolism, and excretion, can vary based on the formulation and preparation method. Preliminary studies suggest that the bioavailability of swertiamarin may be influenced by its solubility and the presence of other constituents in the herbal preparation. Further research is needed to fully elucidate its pharmacokinetic profile.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Loss of appetite
• Headache
• Dizziness

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications

Precautions

• Use with caution in patients with liver or kidney disease
• Monitor blood glucose levels in diabetic patients

Pregnancy

Limited data on safety during pregnancy. Use only if clearly needed.

Breast-feeding

Limited data on excretion in breast milk. Exercise caution.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Dried whole plant
• Powdered extract
• Tinctures

Indications

• Stress relief
• Anxiety management
• Cognitive enhancement
• Improvement of physical performance
• Support for immune function

Dosage

Children: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Adults: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Mechanism of action

The primary active compounds in Cordifolia are known as withanolides, which exhibit a variety of pharmacological effects. These compounds modulate several signaling pathways, including the inhibition of the nuclear factor kappa B (NF-kB) and the activation of the AMP-activated protein kinase (AMPK). This modulation leads to anti-inflammatory, antioxidant, and neuroprotective effects. Additionally, withanolides may influence neurotransmitter levels, thereby aiding in mood regulation and cognitive enhancement.

Pharmacodynamics

Cordifolia demonstrates adaptogenic effects, helping the body resist stressors of various kinds. It has been shown to improve physical endurance, enhance memory and cognitive function, and exert a calming effect on the nervous system. The herb also exhibits immunomodulatory properties, promoting a healthy immune response while reducing inflammation.

Pharmacokinetics

The pharmacokinetics of Cordifolia are not extensively studied compared to conventional pharmaceuticals. However, it is generally understood that withanolides are absorbed in the gastrointestinal tract, undergo hepatic metabolism, and are excreted primarily through urine and feces. The bioavailability of these compounds can be affected by various factors, including formulation and dosage form.

Pregnancy

Insufficient data available; consult healthcare provider.

Breast-feeding

Insufficient data available; consult healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Inflammatory conditions
• Cancer prevention and treatment
• Antioxidant therapy
• Digestive disorders
• Cardiovascular health

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines, as dosages can vary based on the formulation and clinical indication.

Mechanism of action

Curcumin acts as a scavenger of reactive oxygen species, including hydroxyl radicals and superoxide anions, and inhibits lipid peroxidation as well as peroxide-induced DNA damage. It exhibits potent anti-inflammatory and anti-carcinogenic effects by modulating various signaling molecules. Curcumin inhibits protein kinases, c-Jun/AP-1 activation, and cyclooxygenase (COX)-2 activity, impacting cellular signal transduction pathways related to growth and malignant transformation.

Pharmacodynamics

In experimental animal models, curcumin has demonstrated significant pharmacological effects, such as increasing bile flow and inhibiting inflammation and edema formation. It has been shown to decrease cell proliferation and promote apoptosis in cancer cells. Additionally, curcumin inhibits platelet aggregation induced by arachidonic acid, suggesting its role in cardiovascular health.

Pharmacokinetics

Curcumin's pharmacokinetics are characterized by low bioavailability due to rapid metabolism and systemic elimination. It undergoes extensive hepatic metabolism, leading to the production of several metabolites. The absorption of curcumin can be enhanced by co-administration with piperine. Oral bioavailability remains a challenge, which has led to the exploration of various formulations to improve its therapeutic efficacy.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications
• May interfere with the metabolism of certain drugs due to inhibition of cytochrome P450 enzymes

Precautions

• Use with caution in patients with gallbladder disease
• Monitor patients on anticoagulant therapy
• Caution in patients with diabetes due to potential hypoglycemic effects

Pregnancy

Safety during pregnancy has not been established, caution is advised.

Breast-feeding

Curcumin may be excreted in breast milk, caution is advised.

Storage

Store in a cool, dry place away from light.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extracts

Indications

• Antioxidant support
• Enhancement of immune function
• Skin health improvement
• Digestive health support
• Metabolic syndrome management
• Hepatoprotective therapy

Dosage

Children: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in emblica, particularly emblicanin A and B, have been shown to exhibit antioxidant activity by scavenging free radicals and reducing oxidative stress. This action helps protect cells from damage, particularly in the liver and other organs. Additionally, emblica may modulate various biochemical pathways, including the enhancement of glutathione levels, which is critical for detoxification and cellular protection.

Pharmacodynamics

Emblica demonstrates a range of pharmacological effects, including anti-inflammatory, antimicrobial, and hepatoprotective actions. The fruit has been found to improve lipid profiles and glucose metabolism, making it potentially beneficial for metabolic syndrome and diabetes management. Furthermore, its immunomodulatory properties can enhance the immune response, contributing to overall health.

Pharmacokinetics

The pharmacokinetics of emblica are not extensively studied; however, its active compounds are believed to be rapidly absorbed in the gastrointestinal tract. The bioavailability and half-life of these compounds can be influenced by factors such as formulation and concurrent food intake. Metabolism primarily occurs in the liver, and excretion is likely via both renal and biliary pathways.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Nausea
• Vomiting
• Allergic reactions

Interactions

• May interact with anticoagulants, enhancing their effects
• Possible antagonism with certain chemotherapy agents

Precautions

• Use with caution in individuals with allergies to plants in the Euphorbiaceae family
• Monitor blood sugar levels in diabetic patients

Pregnancy

Limited human data available; use only if clearly needed and benefits outweigh risks.

Breast-feeding

Limited data available; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered extract
• Capsules
• Tablets
• Liquid extract

Indications

• Diabetes mellitus
• Digestive disorders
• Hepatoprotective agent
• Antioxidant therapy
• Anti-inflammatory conditions

Dosage

Children: Refer to established guidelines and clinical protocols, as specific dosing for Enicostemma is not standardized.

Adults: Refer to established guidelines and clinical protocols, as specific dosing for Enicostemma is not standardized.

Mechanism of action

The exact mechanism of action of Enicostemma is not fully understood, but it is believed to exert its effects primarily through the modulation of glucose metabolism. Compounds in Enicostemma may enhance insulin secretion from pancreatic beta cells and improve peripheral insulin sensitivity. Additionally, it is thought to have antioxidant properties that help in reducing oxidative stress associated with diabetes and other metabolic disorders.

Pharmacodynamics

Enicostemma exhibits a range of pharmacodynamic effects, including hypoglycemic activity, hepatoprotective effects, and anti-inflammatory properties. Its active constituents may help in lowering blood glucose levels, improving lipid profiles, and protecting liver cells from damage due to toxins or oxidative stress. The plant has also been reported to stimulate appetite and aid in digestion.

Pharmacokinetics

Information on the pharmacokinetics of Enicostemma is limited due to the variability in its active compounds and their absorption, distribution, metabolism, and excretion profiles. Generally, the bioavailability of herbal compounds can be influenced by factors such as formulation, dosage, and individual patient characteristics. Further studies are needed to elucidate the pharmacokinetic properties of the specific active constituents in Enicostemma.

Pregnancy

There is insufficient data on the safety of enicostemma during pregnancy. It is advisable to avoid use unless prescribed by a healthcare professional.

Breast-feeding

There is limited information available on the excretion of enicostemma in breast milk. Caution is recommended when using this herb while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anti-inflammatory treatment
• Antimicrobial therapy
• Antioxidant support
• Traditional herbal medicine applications

Dosage

Children: Refer to the BNF for Children for appropriate dosing guidelines, as specific pediatric dosing for eugenia is not established.

Adults: Refer to specific guidelines or clinical protocols for dosing recommendations, as eugenia does not have standardized dosing for adults in conventional medical practice.

Mechanism of action

Eugenia compounds are believed to exert their effects through multiple pathways, including the modulation of inflammatory mediators and the inhibition of microbial growth. Specific mechanisms may involve the scavenging of free radicals and the reduction of oxidative stress, contributing to their observed pharmacological activities.

Pharmacodynamics

Eugenia displays various pharmacodynamic properties, including anti-inflammatory and antimicrobial actions. The effects may result from the compound's interaction with cellular signaling pathways, influencing the production of cytokines and enzymes involved in inflammatory processes. Additionally, eugenia may enhance the body's antioxidant defenses, contributing to its overall therapeutic potential.

Pharmacokinetics

The pharmacokinetic profile of eugenia, including absorption, distribution, metabolism, and excretion, is not extensively characterized. However, compounds within the Eugenia genus are generally expected to be absorbed in the gastrointestinal tract, distributed throughout the body, and metabolized primarily in the liver. The elimination of eugenia metabolites may occur through renal pathways, but specific data on half-life and clearance rates are limited.

Pregnancy

The safety of eugenia during pregnancy has not been established. Use only if clearly needed and after assessing the potential benefits and risks.

Breast-feeding

Eugenia should be used with caution during breastfeeding. The effects on the nursing infant are unknown.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Indications

• Type 2 diabetes
• Obesity management
• Sugar cravings

Dosage

Children: Refer to current clinical guidelines or product-specific recommendations as dosages can vary.

Adults: Refer to current clinical guidelines or product-specific recommendations as dosages can vary.

Mechanism of action

Gymnema sylvestre works primarily by inhibiting the intestinal absorption of glucose, which may help lower blood sugar levels. Gymnemic acids may also block sugar receptors on the taste buds, reducing the perception of sweetness. Additionally, it may stimulate insulin secretion from pancreatic beta cells and promote regeneration of these cells, thereby enhancing glucose uptake and metabolism.

Pharmacodynamics

The pharmacodynamics of gymnema involve its role in modulating glucose metabolism and appetite regulation. By inhibiting glucose absorption and reducing sugar cravings, gymnema can help maintain optimal blood sugar levels. Its influence on insulin secretion adds a layer of efficacy in managing conditions like type 2 diabetes, although the exact mechanisms remain under investigation.

Pharmacokinetics

The pharmacokinetics of gymnema are not thoroughly characterized in clinical studies. However, it is known that gymnemic acids are absorbed in the gastrointestinal tract, with their effects being dose-dependent. The duration of action and specific metabolic pathways are still subjects of ongoing research, but it is generally considered to have a relatively short half-life.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Hypoglycemia

Interactions

• May enhance the effects of diabetes medications, leading to increased risk of hypoglycemia

Precautions

• Use with caution in individuals with diabetes or hypoglycemia
• Monitor blood sugar levels regularly during use

Pregnancy

Insufficient reliable information is available; consult a healthcare provider before use.

Breast-feeding

Insufficient reliable information is available; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Capsules
• Tablets
• Powder extracts

Indications

• Diabetes mellitus
• Hyperglycemia
• Digestive disorders
• Antioxidant support

Dosage

Children: Pediatric dosing information for jambolana is not well-established. It is advisable to consult healthcare professionals for appropriate dosing in children.

Adults: Dosing for jambolana may vary based on the form used; however, refer to product-specific guidance for accurate dosing. Generally, it's advised to consult healthcare providers for personalized dosage recommendations.

Mechanism of action

The active compounds in jambolana, such as jambosine and anthocyanins, are believed to exert their effects by modulating glucose metabolism. Jambosine has been shown to inhibit the activity of alpha-glucosidase, an enzyme responsible for carbohydrate digestion, thereby reducing glucose absorption in the intestines. Additionally, the antioxidant properties of anthocyanins may help mitigate oxidative stress associated with diabetes.

Pharmacodynamics

Jambolana exhibits hypoglycemic effects, which can help lower blood glucose levels in individuals with diabetes. The fruit also possesses anti-inflammatory and antioxidant properties, contributing to improved metabolic health. Its bioactive compounds may enhance insulin sensitivity and promote pancreatic function, further aiding in glucose regulation.

Pharmacokinetics

The pharmacokinetics of jambolana have not been extensively studied; however, it is assumed that the active compounds are absorbed in the gastrointestinal tract after consumption. The onset of action may vary depending on the form of the extract used (e.g., powder, tincture, or decoction) and individual patient factors. Metabolism and excretion pathways remain to be fully elucidated.

Adverse effects

• Gastrointestinal disturbances
• Hypoglycemia
• Allergic reactions
• Headache
• Dizziness

Interactions

• May enhance the effects of antidiabetic medications
• Potential interaction with antihypertensive drugs

Precautions

• Use with caution in patients with diabetes
• Monitor blood glucose levels regularly
• Avoid in patients with known allergies to jambolana or related plants

Pregnancy

There is limited data on the safety of jambolana during pregnancy. Consult healthcare professionals before use.

Breast-feeding

Limited information is available on the excretion of jambolana in breast milk. Exercise caution and consult healthcare professionals.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powdered extract
• Capsules
• Liquid extract

Indications

• Pain relief
• Inflammatory conditions
• Fever reduction

Dosage

Children: Refer to the BNF for Children for specific dosing information tailored to paediatric populations.

Adults: Refer to clinical guidelines or the product monograph for specific dosing information as it may vary based on indication and severity of condition.

Mechanism of action

Littorale acts through the inhibition of certain inflammatory pathways, primarily by modulating the activity of cyclooxygenase enzymes (COX-1 and COX-2) which are involved in the conversion of arachidonic acid to prostaglandins, thus reducing the synthesis of inflammatory mediators.

Pharmacodynamics

The pharmacodynamic profile of littorale includes its ability to reduce inflammation and pain by blocking the production of prostaglandins, which are responsible for mediating the inflammatory response and causing pain. This results in an analgesic and antipyretic effect, contributing to its therapeutic efficacy in conditions characterized by inflammation.

Pharmacokinetics

Littorale is typically absorbed well from the gastrointestinal tract, with peak plasma concentrations occurring within a few hours after administration. It is metabolized primarily in the liver, undergoing conjugation and oxidation, and is excreted mainly via the kidneys. The half-life of the drug varies but generally allows for once or twice daily dosing regimens.

Pregnancy

Limited data available. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Limited data available. Use with caution and monitor for any adverse effects in the infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anxiety
• Insomnia
• Nutritional supplement
• Antioxidant support
• Immune system support

Dosage

Children: Refer to authoritative sources for specific dosing information.

Adults: Refer to authoritative sources for specific dosing information.

Mechanism of action

The mechanism of action of Longan is not fully elucidated, but it is believed to exert its effects through the modulation of neurotransmitters, particularly influencing serotonin and gamma-aminobutyric acid (GABA) pathways. The fruit is rich in antioxidants, which may contribute to its protective effects against oxidative stress.

Pharmacodynamics

Longan is known for its high content of vitamins, minerals, and antioxidants, including vitamin C, B vitamins, and polyphenols. These compounds may enhance immune function, promote nervous system health, and improve skin health. Its calming effects may be attributed to constituents that influence neurotransmitter activity.

Pharmacokinetics

The pharmacokinetics of Longan is not well-studied, but as a food source, it is likely to be absorbed through the gastrointestinal tract. The bioavailability of its active compounds may vary depending on preparation methods (fresh, dried, or processed). The metabolism and excretion pathways are not clearly defined in the literature.

Pregnancy

Insufficient data on the safety of longa during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Insufficient data on the excretion of longa in human milk. Caution is advised when using during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Dosage

Children: Refer to established pharmacological guidelines for appropriate medications.

Adults: Refer to established pharmacological guidelines for appropriate medications.

Pregnancy

There is insufficient data on the safety of marsupium during pregnancy. It is advisable to avoid use unless clearly needed and prescribed by a healthcare professional.

Breast-feeding

The safety of marsupium during breastfeeding has not been established. Caution is advised, and consulting a healthcare provider is recommended before use.

Storage

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Indications

• Inflammation
• Pain management
• Antimicrobial infections
• Antipyretic
• Insect repellent

Dosage

Children: Refer to established guidelines and consult relevant literature for specific dosing information, as no standardized dose is available.

Adults: Refer to established guidelines and consult relevant literature for specific dosing information, as no standardized dose is available.

Mechanism of action

The precise mechanism of action of Melia azedarach is not fully elucidated. However, it is believed that the compounds present in the plant inhibit certain enzymes and modulate inflammatory pathways. The flavonoids may exert antioxidant effects, reducing oxidative stress, while other constituents may interact with cellular receptors to exert analgesic effects.

Pharmacodynamics

Melia exhibits anti-inflammatory and analgesic properties, likely through the inhibition of pro-inflammatory cytokines and the modulation of pain pathways. The antioxidant properties of its constituents help in neutralizing free radicals, thereby providing cellular protection. Additionally, some studies suggest that Melia may possess antimicrobial properties, contributing to its use in traditional medicine.

Pharmacokinetics

Information on the pharmacokinetics of Melia azedarach is limited. The absorption, distribution, metabolism, and excretion of its active compounds can vary widely depending on the preparation (e.g., extracts, tinctures) and the method of administration. Generally, it is expected that the bioactive compounds are absorbed in the gastrointestinal tract, with potential hepatic metabolism before systemic circulation.

Pregnancy

Melia species have not been well studied in pregnancy. Caution is advised when considering use.

Breast-feeding

Safety during breastfeeding is not well established. Consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Type 2 diabetes mellitus
• Gastrointestinal disorders
• Inflammatory conditions
• Hyperlipidemia

Dosage

Children: Refer to established guidelines for dosing in children, as specific dosages may vary based on formulation and individual needs.

Adults: Refer to established guidelines for dosing, as specific dosages may vary based on formulation and individual needs.

Mechanism of action

Momordica exhibits its pharmacological effects primarily through the modulation of glucose metabolism. It contains active compounds such as charantin and momordicin, which are believed to enhance insulin sensitivity and promote glucose uptake in cells. Additionally, Momordica may exert antioxidant effects and influence metabolic pathways associated with lipid metabolism.

Pharmacodynamics

The pharmacodynamics of Momordica are characterized by its ability to lower blood glucose levels and improve insulin sensitivity. Studies suggest that it may also have anti-inflammatory and anti-cancer properties. Its effects on glucose metabolism may involve the stimulation of pancreatic beta-cell function and the inhibition of glucose production in the liver.

Pharmacokinetics

The pharmacokinetics of Momordica are not well-defined due to limited clinical studies. However, it is understood that the bioactive components are absorbed through the gastrointestinal tract. The onset of action for blood glucose-lowering effects can vary based on dosage and individual metabolic responses. Metabolism and elimination pathways are not thoroughly characterized, necessitating further research.

Adverse effects

• Gastrointestinal disturbances
• Hypoglycemia
• Allergic reactions

Interactions

• May enhance the effects of antidiabetic medications
• Potential interaction with anticoagulants

Precautions

• Use with caution in patients with diabetes due to potential hypoglycemic effects
• Monitor blood sugar levels closely in diabetic patients
• Avoid use in pregnant and breastfeeding women unless advised by a healthcare professional

Pregnancy

Safety in pregnancy has not been established. Use with caution and only if necessary.

Breast-feeding

Safety during breastfeeding is not well established. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried fruit extract
• Capsules
• Powder

Indications

• Anxiety
• Sleep disorders
• Stress relief
• Mild depression
• Digestive issues

Dosage

Children: Dosage for paediatric patients should be determined by a qualified healthcare provider familiar

Adults: Dosage varies widely depending on the specific officinalis species and preparation. General guidance for herbal preparations should be followed, and consulting a healthcare professional is recommended.

Mechanism of action

The mechanism of action of officinalis species varies depending on the specific plant. For example, Melissa officinalis is thought to exert its effects primarily through modulation of GABA (gamma-aminobutyric acid) receptors, which are crucial for inhibitory neurotransmission in the brain. This interaction can lead to a calming effect, reducing anxiety and promoting sleep. Valeriana officinalis is believed to enhance GABAergic activity, potentially increasing GABA concentrations in the synaptic cleft, further contributing to its sedative properties.

Pharmacodynamics

Pharmacodynamics of officinalis species involve their effects on the central nervous system. The herbs are known to promote relaxation, reduce anxiety, and improve sleep quality. Their bioactive compounds, such as flavonoids and essential oils, are thought to influence neurotransmitter systems, particularly GABA, which plays a key role in anxiety regulation. Additionally, these plants may exhibit antioxidant properties, contributing to overall health benefits.

Pharmacokinetics

Pharmacokinetics of officinalis species can vary widely based on the specific plant and its preparation. Generally, the active components are absorbed in the gastrointestinal tract after ingestion. The onset of action can occur within 30 minutes to several hours, depending on the formulation. Metabolism occurs primarily in the liver, with elimination through urine. The half-life of the active compounds may vary, necessitating multiple doses for sustained effects.

Pregnancy

Consult healthcare provider before use. Limited data on safety in pregnancy.

Breast-feeding

Consult healthcare provider before use. Limited data on safety while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anti-inflammatory treatment
• Antioxidant therapy
• Antimicrobial applications
• Management of chronic diseases associated with oxidative stress

Dosage

Children: Dosing information for pediatric patients is not specified; refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Dosing information for adults is not specified; refer to established guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

Pterocarpus contains various bioactive compounds such as flavonoids, isoflavonoids, and tannins. These compounds are believed to exert their therapeutic effects through multiple mechanisms, including the inhibition of pro-inflammatory cytokines and modulation of oxidative stress pathways. The antioxidant properties of Pterocarpus extract help in scavenging free radicals and reducing cellular damage.

Pharmacodynamics

The pharmacodynamics of Pterocarpus involve its ability to interact with various biochemical pathways. The anti-inflammatory effects are primarily due to the suppression of inflammatory mediators like nitric oxide and prostaglandins. The antioxidant action is crucial in protecting cells from oxidative stress, thereby reducing the risk of chronic diseases linked to inflammation and oxidative damage.

Pharmacokinetics

Limited pharmacokinetic data is available for Pterocarpus. Generally, the absorption, distribution, metabolism, and excretion of its active compounds can vary widely based on the specific species and preparation form (e.g., extracts versus whole plant). Factors such as dosage, route of administration, and individual patient metabolism can influence these pharmacokinetic parameters.

Pregnancy

There is insufficient reliable information regarding the safety of pterocarpus during pregnancy. It is advisable to avoid use unless prescribed by a healthcare professional.

Breast-feeding

There is no available data on the excretion of pterocarpus in human milk. Caution is recommended when using this product during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight and out of reach of children.

Dosage

Children: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Adults: Refer to specific drug formulations and product labels as purified substances can vary widely in their use and dosing.

Mechanism of action

The mechanism of action for purified compounds varies widely depending on the specific substance. Generally, purified drugs exert their effects by interacting with specific biological targets, such as receptors, enzymes, or ion channels, leading to a desired therapeutic effect. This interaction can involve binding to receptors to activate or inhibit signaling pathways, modulating enzymatic activity, or altering physiological processes.

Pharmacodynamics

Pharmacodynamics describes the effects of a drug on the body and the relationship between drug concentration and effect. For purified drugs, this can involve dose-response relationships and the time course of their action. The purified form often enhances potency and reduces variability in response among patients, which can lead to more predictable therapeutic outcomes. The overall effect is determined by the drug's affinity for its target, the efficacy of the drug-receptor interaction, and the downstream signaling pathways activated as a result of this interaction.

Pharmacokinetics

Pharmacokinetics involves the absorption, distribution, metabolism, and excretion (ADME) of a drug. For purified substances, absorption can be more efficient due to the absence of impurities that may affect solubility or stability. Distribution may also be enhanced, leading to higher bioavailability. Metabolism can be influenced by the structure of the purified compound, as it may be metabolized more readily by liver enzymes. Excretion typically occurs through the kidneys or liver, depending on the molecular characteristics of the purified drug.

Pregnancy

Consult with a healthcare professional, as the safety of purified forms of medications during pregnancy may vary depending on the specific substance.

Breast-feeding

Consult with a healthcare professional, as the safety of purified forms of medications during breastfeeding may vary depending on the specific substance.

Storage

Store in a cool, dry place, away from light and moisture, and keep out of reach of children.

Indications

• Gastrointestinal disorders
• Liver diseases
• Fever
• Digestive aid
• Antioxidant support

Dosage

Children: Dosage recommendations for children are not established; consult a healthcare provider for guidance.

Adults: Dosage varies based on formulation and indication, consult specific herbal preparation guidelines for precise dosing.

Mechanism of action

The active compounds in Swertia, including swertiamarin and other iridoid glycosides, are thought to exert their effects by modulating various biochemical pathways. These compounds may influence liver function, promote bile secretion, and exert antioxidant effects. Additionally, they can exhibit anti-inflammatory and antimicrobial activities, contributing to the overall therapeutic profile of Swertia.

Pharmacodynamics

Swertia is believed to enhance digestive functions and support liver health through its bitter principles, which stimulate the secretion of digestive enzymes and bile. The compounds have shown potential in promoting antioxidant activity, which may help protect cells from oxidative stress. Some studies suggest that Swertia may also influence glucose metabolism and exhibit anti-diabetic properties.

Pharmacokinetics

Data on the pharmacokinetics of Swertia is limited, but it is known that the bioavailability of its active components can vary based on the formulation and route of administration. It is generally acknowledged that oral administration leads to absorption in the gastrointestinal tract, where it may undergo hepatic metabolism. The elimination of active metabolites is not well characterized, and further studies are needed to elucidate its pharmacokinetic profile.

Adverse effects

• Gastrointestinal disturbances
• Allergic reactions
• Headaches
• Dizziness

Interactions

• May interact with anticoagulants
• Potential interactions with antidiabetic agents

Precautions

• Should be used with caution in patients with liver disease
• Monitor for potential allergic reactions
• Caution in patients taking medications that affect blood sugar levels

Pregnancy

Insufficient evidence available regarding safety in pregnancy. Use with caution and consult healthcare professionals.

Breast-feeding

Limited data on excretion in breast milk. Caution is advised.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Dried powder
• Tinctures
• Liquid extracts

Dosage

Children: Refer to established herbal medicine guidelines or consult a healthcare professional for appropriate dosing information.

Adults: Refer to established herbal medicine guidelines or consult a healthcare professional for appropriate dosing information.

Mechanism of action

The precise mechanism of action of sylvestre is not well-documented in scientific literature. Generally, plant extracts like sylvestre may exert their effects through various biochemical pathways, including modulation of inflammatory responses, antioxidant activity, and interaction with metabolic pathways. These mechanisms can involve the regulation of enzyme activity and the modulation of cellular signaling pathways, although specific pathways for sylvestre remain largely undefined.

Pharmacodynamics

Pharmacodynamics of sylvestre is variable depending on the specific chemical constituents present in the extract. Commonly, it may show anti-inflammatory, antioxidant, and potentially metabolic-enhancing effects. The efficacy of sylvestre can be influenced by factors such as dosage, preparation method, and individual patient characteristics. Overall, clinical effects may include improved metabolic function, enhanced energy levels, and potential support for overall health.

Pharmacokinetics

The pharmacokinetics of sylvestre, including absorption, distribution, metabolism, and excretion, are not well-characterized. Generally, herbal extracts are absorbed through the gastrointestinal tract, and their bioavailability can be influenced by factors such as solubility and the presence of other compounds. Metabolism may occur primarily in the liver, with various metabolites potentially contributing to its therapeutic effects. However, specific studies on sylvestre's pharmacokinetics are lacking.

Pregnancy

Insufficient data on the safety of sylvestre during pregnancy. It is advisable to avoid use unless clearly needed.

Breast-feeding

Limited information is available on the excretion of sylvestre in human milk. Caution is recommended when using during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Diabetes mellitus
• Chronic infections
• Inflammatory conditions
• Immunomodulation
• Antioxidant support

Dosage

Children: Refer to specific traditional or herbal medicine guidelines, as there is no standardized dosage established in clinical settings.

Adults: Refer to specific traditional or herbal medicine guidelines, as there is no standardized dosage established in clinical settings.

Mechanism of action

The active compounds in Tinospora, such as tinosporide and other alkaloids, interact with various molecular pathways. They are believed to modulate immune responses by affecting the activity of immune cells, enhancing phagocytosis and promoting the production of cytokines. Additionally, the compounds may exhibit antioxidant effects by scavenging free radicals, thereby reducing oxidative stress.

Pharmacodynamics

Tinospora exerts various pharmacodynamic effects including immunomodulation, anti-inflammatory actions, and potential blood glucose-lowering effects. Its immunomodulatory effects may help enhance the body's defense against infections and diseases. The anti-inflammatory properties can contribute to the alleviation of symptoms in conditions such as arthritis and other inflammatory disorders.

Pharmacokinetics

The pharmacokinetics of Tinospora, including absorption, distribution, metabolism, and excretion, are not well-characterized in the literature. However, it is known that the active components are absorbed in the gastrointestinal tract after oral administration. The metabolites may be processed by the liver, and the elimination half-life can vary. Further studies are needed to fully elucidate the pharmacokinetic profile of Tinospora extracts.

Adverse effects

• Gastrointestinal upset
• Hypoglycemia
• Allergic reactions

Interactions

• May enhance the effects of antidiabetic medications, increasing the risk of hypoglycemia
• Potential interaction with immunosuppressants due to its immune-modulating effects

Precautions

• Use with caution in patients with diabetes due to potential hypoglycemic effects
• Monitor for allergic reactions in sensitive individuals

Pregnancy

Limited clinical data is available. Caution is advised due to insufficient evidence of safety.

Breast-feeding

Insufficient data available. Caution is advised as it may affect milk production or composition.

Storage

Store in a cool, dry place away from direct sunlight and moisture.

Formulations

• Oral extract
• Powdered form
• Capsules

Indications

• Zinc deficiency
• Copper deficiency
• Immune system support
• Wound healing
• Skin health support

Dosage

Children: Refer to specific guidelines for paediatric dosing, as it is essential to consider age, weight, and clinical condition.

Adults: Refer to specific guidelines for dosage, as it may vary based on the condition being treated and individual patient factors.

Mechanism of action

Zinc acts as a cofactor for numerous enzymes and plays a vital role in cellular processes such as DNA synthesis, protein synthesis, and cell division. Copper is involved in the formation of hemoglobin and collagen, and it also helps in the absorption of iron. Together, they contribute to various biochemical pathways that support immune function and overall health.

Pharmacodynamics

The pharmacodynamics of Yashad is characterized by its role in enhancing immune function, promoting skin integrity, and facilitating wound healing. Zinc is known to modulate the immune response by supporting the activity of T-lymphocytes and influencing cytokine production. Copper contributes to antioxidant defense and is essential for maintaining normal physiological functions.

Pharmacokinetics

Zinc and copper are absorbed in the gastrointestinal tract, with factors such as dietary intake and the presence of other minerals influencing absorption rates. Once absorbed, zinc is distributed throughout the body, primarily in skeletal muscle and bone, while copper is distributed in liver, brain, and kidney tissues. Both minerals are excreted primarily through urine, with zinc also lost in feces.

Pregnancy

The safety of Yashad during pregnancy has not been established. It is recommended to be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Yashad is excreted in breast milk, and caution should be exercised when administered to a nursing mother.

Storage

Store in a cool, dry place, away from direct light. Keep out of reach of children.

Mechanism of action

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2. Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, alpha, beta-unsaturated beta-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The alpha, beta-unsaturated beta-diketone moiety covalently interacts with protein thiols, through Michael reaction. The beta-diketo group forms chelates with transition metals, thereby reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin... The present study demonstrates that curcumin acts as pro-oxidant and sensitizes human lung adenocarcinoma epithelial cells (A549) to apoptosis via intracellular redox status mediated pathway. Results indicated that curcumin induced cell toxicity (light microscopy and MTT assay) and apoptosis (AnnexinV-FITC/PI labeling and caspase-3 activity) in these cells. These events seem to be mediated through generation of reactive oxygen species (ROS) and superoxide radicals (SOR) and enhanced levels of lipid peroxidation. These changes were accompanied by increase in oxidized glutathione (GSSG), reduced glutathione (GSH) and gamma-glutamylcysteine synthetase (gamma-GCS) activity, but decrease in GSH/GSSG ratio. The induction of apoptosis and decrease in GSH/GSSG ratio was also accompanied by sustained phosphorylation and activation of p38 mitogen activated protein kinase (MAPK). On the other hand, addition of N-acetyl cysteine (NAC), an antioxidant, blocked the curcumin-induced ROS production and rescued malignant cells from curcumin-induced apoptosis through caspase-3 deactivation. However, L-buthionine sulfoximine (BSO), a GSH synthesis blocking agent, further enhanced curcumin-induced ROS production and apoptosis in A549 cells. Decreased GSH/GSSG ratio seems to be a crucial factor for the activation of MAPK signaling cascade by curcumin. The study therefore, provides an insight into the molecular mechanism involved in sensitization of lung adenocarcinoma cells to apoptosis by curcumin. Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activiti

Pharmacodynamics

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.